Clinical Trials Browser

Phase 2 × 13-valent pneumococcal vaccine × Plasma cell × Clear all

NCT01349569 2019-01-15

Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission

Phase 2 Completed

19 enrolled 9 charts

Multiple Myeloma